EQS-Ad-hoc: PharmaSGP Holding SE / Key word: Dividend
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
18-Apr-2024 / 20:31 CET/CEST
Disclosure of an.
EQSAdhoc PharmaSGP Holding SE Key word Dividend PharmaSGP Holding SE proposes an increased dividend of EUR 136 per share for 2023 18Apr2024 2031 CETCEST Disclosure of an inside information acc to Art
PharmaSGP Holding SE / Key word(s): DividendPharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 202318-Apr-2024 / 20:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is so.
PharmaSGP Group acquires OTC brand portfolio (Baldriparan, Formigran, Spalt and Kamol) from GSK pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
PharmaSGP : acquires OTC brand portfolio (Baldriparan, Formigran, Spalt and Kamol) from GSK marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.